During the past decade, Northern Michigan Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Northern Michigan Neurology" #1 sponsor was "Genzyme, a Sanofi Company" with 2 trials, followed by "Sunovion" with 2 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored, "Chelsea Therapeutics" with 1 trials sponsored and "Cognition Pharmaceuticals, LLC" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Michigan Neurology" #1 collaborator was "Bayer" with 2 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Eisai Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northern Michigan Neurology" are "Alzheimer's Disease" (4 trials), "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (2 trials), "Parkinson's Disease" (2 trials) and "Acute Ischemic Stroke" (1 trials). Many other conditions were trialed in "Northern Michigan Neurology" in a lesser frequency.

Most popular intervention types in "Northern Michigan Neurology" are "Drug" (11 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "2 mg perampanel" (1 trials), "4 mg perampanel" (1 trials), "AC-3933" (1 trials) and "APL-130277" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northern Michigan Neurology" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Northern Michigan Neurology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Northern Michigan Neurology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Northern Michigan Neurology, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".